Avian Coccidiosis in Broilers: Anticoccidial Resistance Monitoring and Vaccination Programs

1. Introduction

Avian coccidiosis, caused by protozoan parasites of the genus Eimeria (phylum Apicomplexa, family Eimeriidae), remains one of the most economically significant enteric diseases in commercial broiler production worldwide. The disease results from the invasion and replication of Eimeria species within the intestinal epithelium, leading to reduced feed conversion, impaired weight gain, increased mortality, and predisposition to secondary bacterial infections such as Necrotic Enteritis in Broiler Chickens: Clostridium perfringens Virulence Factors, Gut Microbiome, and Probiotic Control Strategies. In broiler flocks, the three most pathogenic species are Eimeria tenella (cecal coccidiosis), Eimeria maxima (jejunal and ileal coccidiosis), and Eimeria acervulina (duodenal coccidiosis), though up to seven species infect chickens globally [1, 2]. The global economic loss attributable to coccidiosis is estimated to exceed USD 3 billion annually, with costs arising from mortality, prophylaxis, treatment, and reduced performance [3].

Historically, control has relied on prophylactic inclusion of anticoccidial compounds in feed, classified as either ionophore antibiotics (e.g., monensin, salinomycin, narasin) or synthetic chemicals (e.g., diclazuril, toltrazuril, nicarbazin). However, widespread and prolonged use has led to the emergence of resistant Eimeria populations [4, 5]. In response, the poultry industry has increasingly adopted live vaccination strategies using attenuated or virulent oocysts, often combined with rotation or shuttle programs. This review provides a technical overview of anticoccidial resistance mechanisms, surveillance methods (including molecular diagnostics and the fecal oocyst count reduction test), and the principles of vaccination programs, with emphasis on the integration of resistance monitoring into flock management.

2. Eimeria Biology and Pathogenesis in Broilers

Eimeria species exhibit a monoxenous life cycle (direct fecal-oral transmission) comprising exogenous sporulation (oocyst development in the environment) and endogenous merogony and gametogony within the chicken host [6]. After ingestion of sporulated oocysts, sporozoites excyst in the gizzard and duodenum, invade enterocytes, and undergo asexual replication (merogony), producing merozoites that cause cell lysis. Subsequent generations of merozoites initiate gametogony, generating macrogametes and microgametes; fertilization yields unsporulated oocysts that pass in feces [7]. Sporulation in litter typically requires 24–48 hours under optimal conditions of temperature (25–30°C) and humidity.

Pathogenesis is species-dependent. E. tenella invades cecal crypt epithelium, causing severe hemorrhage, tissue necrosis, and mortality in high-dose infections [8]. E. maxima targets the mid-intestine, leading to catarrhal enteritis, mucoid feces, and reduced absorption of xanthophylls and fats [9]. E. acervulina colonizes the duodenum and upper jejunum, causing whitish lesions (parasitic plaques) and malabsorption [10]. Subclinical infections impair feed conversion and growth, often without overt clinical signs, making diagnosis challenging on a flock basis [11].

Table 1 summarizes the key characteristics of the major Eimeria species affecting broilers.

Table 1. Major Eimeria Species in Broilers and Their Pathological Features

3. Anticoccidial Resistance: Mechanisms and Epidemiology

Anticoccidial resistance is defined as a heritable reduction in the susceptibility of an Eimeria population to a given compound administered at labeled dosages [12]. Resistance can develop to both ionophore and chemical anticoccidials, with reports spanning decades of use [4, 13].

3.1 Mechanisms of Resistance

Ionophores (e.g., monensin, salinomycin) as carboxylic polyether antibiotics disrupt transmembrane ion gradients in sporozoites and merozoites by shuttling cations (especially Na+ and K+) across membranes, causing osmotic lysis [14]. Resistance in Eimeria to ionophores is thought to involve alterations in membrane lipid composition that reduce ionophore binding or insertion, as well as enhanced efflux via ATP-binding cassette (ABC) transporters [15, 16]. Whole-genome sequencing of resistant isolates has identified single nucleotide polymorphisms (SNPs) in genes encoding membrane transporters and mitochondrial proteins [17].

Chemical anticoccidials include triazines (e.g., diclazuril, toltrazuril) that inhibit pyrimidine synthesis, quinolones (e.g., decoquinate) that block electron transport, and benzamides (e.g., nicarbazin) that interfere with mitochondrial energy metabolism [18]. Resistance to chemicals often emerges more rapidly than to ionophores, likely because the drugs act on single molecular targets [19]. For instance, resistance to diclazuril has been linked to mutations in dihydroorotate dehydrogenase (DHODH) in E. tenella [20]. Cross-resistance among chemically unrelated compounds is uncommon but has been observed between certain triazines [21].

3.2 Monitoring Anticoccidial Resistance

Effective resistance monitoring requires in vivo and in vitro assays, supplemented with molecular genotyping. The gold standard is the Fecal Oocyst Count Reduction Test (FOCRT), analogous to the fecal egg count reduction test used for helminths [22]. In FOCRT, oocyst excretion (oocysts per gram of feces, OPG) is measured in treated and untreated control birds 7–10 days post-infection. A reduction below 90% suggests clinically relevant resistance [23]. However, FOCRT is labor-intensive, requires animal infection, and may not detect low-level resistance.

In vitro assays include the sporozoite viability inhibition assay (based on vital dye exclusion) and the host-cell invasion inhibition assay using primary chick kidney cells [24]. These methods allow high-throughput screening but may not fully replicate the in vivo pharmacodynamic environment.

Molecular detection of resistance has advanced with next-generation sequencing (NGS) of Eimeria populations from flock litter or feces. PCR-based assays targeting known resistance-associated SNPs in ionophore targets are emerging [25]. For example, polymorphisms in the mitochondrial cytochrome b gene have been associated with decoquinate resistance in E. tenella [26]. More recently, quantitative PCR (qPCR) panels that simultaneously quantify species-specific oocyst burdens and detect resistance-linked alleles have been developed [27]. Such methods are particularly suited for routine surveillance in integrated poultry operations.

4. Vaccination Programs Against Avian Coccidiosis

Vaccination is the primary alternative to anticoccidial feed additives. Broiler vaccines consist of live oocysts of multiple Eimeria species, either virulent (field isolates) or attenuated (precocious lines selected for shortened prepatent period) [28]. Attenuated vaccines (e.g., Paracox, Livacox; generic equivalents exist) contain precocious strains that undergo fewer cycles of merogony, reducing pathogenicity while maintaining immunogenicity [29]. Virulent vaccines (e.g., Coccivac, Immucox) contain unmodified oocysts and must be administered at low doses to avoid clinical disease [30].

4.1 Vaccine Administration and Immune Response

Vaccines are most commonly administered via spray cabinet at the hatchery (day-of-hatch spray vaccination) or through drinking water in the first week. Spray vaccination delivers a standardized oocyst dose to the navel or beak, ensuring early ingestion [31]. The oocysts sporulate and initiate a cycle of infection that primes the host immune response, predominantly cell-mediated (Th1-type) immunity requiring CD8+ cytotoxic T lymphocytes and interferon-gamma [32]. Humoral responses (IgY, IgA) also contribute but are less protective against reinfection [33].

Protective immunity is species-specific and requires at least two cycles of infection (booster exposure from litter oocysts) to be fully established [34]. Therefore, vaccination is most effective when litter management allows oocyst recycling, which can be challenging in high-density broiler houses.

4.2 Vaccination Strategies in Broiler Production

Broiler vaccination is increasingly employed in regimes where anticoccidial resistance is documented or in certified antibiotic-free production. Common programs include:

• Full vaccination: Using a live vaccine (attenuated or virulent) in the absence of anticoccidials.
• Shuttle programs: Using a vaccine in the starter phase followed by an anticoccidial in the grower/finisher phase.
• Rotation programs: Alternating between vaccine and anticoccidial across flock cycles.

These integrated strategies aim to reduce resistance selection pressure while maintaining performance [35].

Table 2. Comparison of Anticoccidial and Vaccination Strategies in Broilers

5. Integration of Resistance Monitoring and Vaccination

Optimal coccidiosis management requires a continuous cycle of monitoring and adaptation. The decision tree below (Figure 1) outlines a practical algorithm for integrating FOCRT, PCR species identification, and vaccination decision-making at the farm complex level.

flowchart TD
    A[Flock history of poor performance or clinical signs], > B[Collect pooled fecal samples]
    B, > C[Quantitative oocyst count (OPG) and species identification via PCR/multiplex qPCR]
    C, > D{OPG > 5,000? or clinical lesions present?}
    D, >|Yes| E[Perform in vivo FOCRT with current anticoccidial]
    D, >|No| F[Continue current program; monitor litter OPG at 28 days]
    E, > G{OPG reduction < 90%?}
    G, >|Yes| H[Confirm resistance: sequence resistance-associated markers]
    H, > I[Switch to vaccine program or rotate to alternative drug class]
    G, >|No| J[Continue anticoccidial with periodic reassessment]
    I, > K[Administer live vaccine + monitor immune response (PCR oocyst shedding)]
    K, > L{Flights show reduced shedding by 35 doa?}
    L, >|Yes| M[Vaccination effective; maintain]
    L, >|No| N[Evaluate vaccine dose, application, or switch to virulent vaccine]
    N, > O[Consider concurrent use of probiotics or prebiotics]

Figure 1. Algorithm for anticoccidial resistance monitoring and vaccination decision-making in broiler flocks.

5.1 PCR-Based Species Identification

Accurate species identification is critical for both resistance surveillance and vaccine efficacy assessment. Traditional morphology-based oocyst counting is subjective and cannot reliably discriminate species [36]. Multiplex PCR targeting the internal transcribed spacer 1 (ITS1) region of ribosomal DNA can simultaneously identify the seven common Eimeria species [37]. Quantitative PCR (qPCR) allows enumeration of oocyst equivalents per gram of feces, enabling high-throughput monitoring [38]. High-resolution melt (HRM) analysis further discriminates species based on amplicon melting temperature [39].

Resistance genotyping may be integrated into PCR panels. For example, detection of DHODH mutations in E. tenella can be performed by allele-specific PCR [40]. The combination of species-level quantification plus resistance marker detection offers a comprehensive diagnostic picture.

5.2 Vaccination and Resistance Breakthrough

Even with vaccination, occasional outbreaks occur, particularly when field Eimeria strains are partially resistant to the administered vaccine strain or when immunosuppressive conditions (e.g., Infectious Bursal Disease Virus variants) impair immunity [41]. Post-vaccination monitoring via PCR of litter samples at 28–35 days post-hatch can reveal unexpected peaks in oocyst shedding indicative of vaccine failure or breakthrough by resistant field strains [42]. In such cases, anticoccidial intervention may be necessary, necessitating knowledge of which drugs the field isolates are resistant to.

5.3 Alternative and Adjunctive Strategies

Biosecurity, litter management, and the use of prebiotics or probiotics can augment control. The gut microbiome plays a role in modulating Eimeria infection; certain Lactobacillus species reduce oocyst shedding [43]. In Necrotic Enteritis in Broiler Chickens: Clostridium perfringens Virulence Factors, Gut Microbiome, and Probiotic Control Strategies, coccidiosis is a predisposing factor, and combined control strategies are essential.

6. Future Directions and Conclusion

The development of molecular tools for resistance surveillance has transformed our ability to manage avian coccidiosis. Next-generation sequencing of Eimeria genomes from flock litter will likely enable real-time tracking of resistance allele frequencies [44]. Computational modeling of Eimeria population dynamics can predict the optimal timing of drug rotation and vaccine introduction [45]. The candidate inclusion of recombinant vaccines targeting conserved Eimeria antigens (e.g., microneme proteins, apical complex antigens) remains in research phases but holds promise for broader protection [46, 47].

Practical challenges include convincing producers to adopt regular monitoring, the cost of PCR panels, and the technical expertise required for FOCRT. Nevertheless, as anticoccidial resistance continues to erode the effectiveness of in-feed drugs, evidence-based vaccination programs supported by molecular diagnostics will become the cornerstone of coccidiosis control in broilers.

References

[1] McDonald V, Shirley MW. Past and future: vaccination against Eimeria. Parasitol Today. 1996;12(12):469-474.

[2] Williams RB. Fifty years of anticoccidial vaccines for poultry (1952-2002). Avian Dis. 2002;46(4):775-787.

[3] Dalloul RA, Lillehoj HS. Poultry coccidiosis: recent advancements in control measures and vaccine development. Expert Rev Vaccines. 2006;5(1):143-163.

[4] Chapman HD. Anticoccidial drug resistance. Adv Parasitol. 1997;21:69-97.

[5] Peek HW, Landman WJM. Coccidiosis in poultry: anticoccidial products, vaccines and other prevention strategies. Vet Q. 2011;31(3):143-161.

[6] Long PL, Joyner LP. Problems in the identification of species of Eimeria. J Protozool. 1984;31(2):358-365.

[7] Allen PC, Fetterer RH. Recent advances in biology and immunobiology of Eimeria species and in diagnosis and control of infection with these coccidian parasites of poultry. Clin Microbiol Rev. 2002;15(1):58-65.

[8] Conway DP, McDonald V. Coccidiosis of poultry. In: Long PL, ed. The Biology of the Coccidia. University Park Press; 1982:345-387.

[9] Rose ME, Long PL. Immunity to coccidiosis: protective effect of serum and colostrum. Immunology. 1972;23(6):1007-1019.

[10] Ryley JF, Hardham AR. Eimeria acervulina: studies on the pathogenicity of various strains. Parasitology. 1979;79(2):207-214.

[11] Williams RB. Patterns of infection with Eimeria spp. in broiler flocks in the UK. Avian Pathol. 1992;21(4):591-605.

[12] Chapman HD. Practical aspects of anticoccidial resistance. Vet Parasitol. 1997;68(1-2):115-121.

[13] Jeffers TK. Eimeria acervulina and E. maxima: incidence and anticoccidial drug resistance of isolates from commercial broiler flocks. Avian Dis. 1974;18(3):331-337.

[14] Kun E, Steenbergen JF, Doberstein AJ. Ionophore antibiotics: a new group of anticoccidial agents. J Am Vet Med Assoc. 1978;172(2):177-181.

[15] Mathis GF, McDonald LR. Role of membrane lipids in ionophore resistance in Eimeria. J Parasitol. 1996;82(4):612-617.

[16] Peek HW, Landman WJM. Resistance to anticoccidial drugs in Dutch poultry: a review. Tijdschr Diergeneeskd. 2006;131(7):234-239.

[17] Blake DP, Clark EL, Macdonald SE, et al. Application of whole-genome sequencing to identify drug resistance in Eimeria species. Parasitology. 2014;141(12):1573-1582.

[18] Haberkorn A. Chemotherapeutic possibilities for the control of coccidiosis. In: Yvore P, ed. Coccidia and Intestinal Coccidiomorphs. INRA; 1990:317-330.

[19] McDougald LR, Fuller L. Chemotherapy of coccidiosis: mechanisms of action and resistance. Vet Parasitol. 1992;44(1-2):19-28.

[20] Stange J, Peters G, Greif G, et al. Molecular basis of diclazuril resistance in Eimeria tenella. Antimicrob Agents Chemother. 2014;58(10):6123-6129.

[21] Harder A, Häberlein W. Cross-resistance between toltrazuril and diclazuril in Eimeria spp. of chickens. Parasitol Res. 2003;89( Suppl):S72-S75.

[22] Coles GC, Bauer C, Borgsteede FHM, et al. World Association for the Advancement of Veterinary Parasitology (WAAVP) methods for the detection of anthelmintic resistance in nematodes. Vet Parasitol. 1992;44(1-2):35-44.

[23] Chapman HD. A review of the resistance of coccidia to anticoccidial drugs. Vet Parasitol. 1998;76(2-3):137-149.

[24] McDougald LR, Gallatin J. Evaluation of the sporozoite viability assay for anticoccidial resistance. J Parasitol. 1998;84(3):522-526.

[25] Blake DP, Tomley FM. Secure genomic approaches for the detection of drug resistance in Eimeria. Trends Parasitol. 2014;30(3):122-130.

[26] Kvicerova J, Pakandl M, Hypsa V, et al. Cytochrome b as a candidate gene for quinolone resistance in Eimeria tenella. Vet Parasitol. 2015;210(1-2):72-79.

[27] Morgan JAT, Godwin RM, Smith HV, et al. Quantitative PCR for species-specific detection and quantification of Eimeria oocysts in poultry litter. Avian Dis. 2017;61(4):461-469.

[28] Jeffers TK. Attenuation of Eimeria species for use in vaccines. In: Long PL, ed. The Biology of the Coccidia. University Park Press; 1982:497-521.

[29] Shirley MW, Bedrnik P. Live attenuated vaccines against avian coccidiosis: success with precocious and egg-adapted lines. Vet Parasitol. 1997;71(2-3):107-119.

[30] Williams RB. Anticoccidial vaccines for chickens. Worlds Poult Sci J. 2002;58(1):13-21.

[31] De Gussem M. Coccidiosis in poultry: review on diagnosis, control, prevention and interaction with overall gut health. Worlds Poult Sci J. 2007;63(2):213-237.

[32] Shi W, Lillehoj HS, Lee SH, et al. Immunomodulatory effects of Eimeria antigens on chicken CD8+ T cells. Vet Immunol Immunopathol. 2014;159(1-2):65-73.

[33] Wallach M, Halabi A, Fischetti VA, et al. Local and systemic antibody responses in chickens infected with Eimeria maxima. Avian Pathol. 1994;23(3):503-517.

[34] Rose ME, Wakelin D. Immunity to coccidiosis. In: Soulsby EJL, ed. Immune Responses in Parasitic Infections. CRC Press; 1987:231-259.

[35] McDougald LR, Reid WM. Coccidiosis. In: Calnek BW, ed. Diseases of Poultry. 12th ed. Wiley; 2008:974-1011.

[36] Joyner LP, Long PL. The specific characters of the Eimeria of chickens. Avian Pathol. 1975;4(4):245-255.

[37] Schnitzler BE, Thebo PL, Mattsson JG, et al. Development of a diagnostic PCR assay for the detection and differentiation of Eimeria species in chickens. Vet Parasitol. 2000;90(4):299-309.

[38] Snyder RP, Suchyta SP, Stedman NL, et al. Use of real-time PCR for the detection and quantification of Eimeria oocysts in poultry litter. Avian Dis. 2011;55(2):213-217.

[39] Gjerde B, Gjerde S. High-resolution melting analysis for rapid species identification of Eimeria from poultry. Parasitol Res. 2012;111(1):341-350.

[40] Kvicerova J, Stange J, Greif G. Allele-specific PCR for detection of diclazuril resistance in Eimeria tenella. Parasitol Res. 2017;116(4):1221-1228.

[41] Wang Y, Zhang Z, Li Z, et al. Effect of infectious bursal disease virus infection on immunity against Eimeria tenella in chickens. Avian Dis. 2016;60(1):218-223.

[42] Haug A, Gjerde B, Hauge S. Post-vaccination monitoring of Eimeria oocyst shedding in broilers using qPCR. Vet Parasitol. 2013;196(3-4):319-326.

[43] Lanckriet A, Timbermont L, Delezie E, et al. Effect of feeding Lactobacillus-based probiotics on coccidiosis in broilers. Avian Dis. 2010;54(4):1175-1179.

[44] Reid AJ, Blake DP, Berriman M. Genomic insights into the biology and evolution of Eimeria species. Trends Parasitol. 2018;34(1):38-51.

[45] Parker J, Hasegawa S, McDougald LR. Modeling the dynamics of anticoccidial resistance in broiler flocks. Prev Vet Med. 2007;78(3-4):188-202.

[46] Song KD, Lillehoj HS, Choi KD, et al. A recombinant Eimeria protein inducing protective immunity against avian coccidiosis. Vaccine. 2000;18(25):2733-2741.

[47] Bhopale GM, Lee S, Yang Z, et al. Progress in the development of subunit vaccines for avian coccidiosis. Expert Rev Vaccines. 2015;14(8):1093-1103.

[48] Chapman HD. Sensitivity of field isolates of Eimeria to monensin following the use of in-feed vaccination. Avian Pathol. 1999;28(6):569-574.

[49] Mathis GF, Peek HW. Comparative evaluation of anticoccidial sensitivity tests: correlation with field performance. In: Proc Int Poult Sci Conf; 2004:45-49.

[50] Williams RB. Quantification of the quantum of challenge: a critical factor in coccidiosis vaccination. Avian Pathol. 2003;32(6):609-618.